Further data on the usefulness of combined high-dose estrogen and human menopausal gonadotropins for cervical factor.
We report here our series of seven patients treated for cervical infertility with combined high-dose conjugated estrogen and human menopausal gonadotropins. Nine of 11 treatment cycles (81.8%) were ovulatory, and 57.1% of treated patients conceived (three single pregnancies and one set of quadruplets). Criteria for selection of patients for this combined therapy are established.
D000328:Adult; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D008596:Menotropins / Q000627:therapeutic use*; D010060:Ovulation / Q000187:drug effects; D002577:Uterine Cervical Diseases / Q000188:drug therapy*
D006063:Chorionic Gonadotropin; D004966:Estrogens, Conjugated (USP); D002996:Clomiphene; D004997:Ethinyl Estradiol; D008596:Menotropins